<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Guide to polymyalgia rheumatica - inflammatory condition causing muscle pain and stiffness in older adults, diagnosis and treatment.">
    <meta name="keywords" content="polymyalgia rheumatica, PMR, muscle pain elderly, inflammatory muscle pain, shoulder hip stiffness">
    <title>Polymyalgia Rheumatica | ChronicSoreness</title>
    <link rel="stylesheet" href="../css/styles.css">
</head>
<body>
    <header class="header"><nav class="nav-container"><div class="logo"><a href="../index.html"><span class="logo-icon">ðŸ’œ</span><span class="logo-text"><strong>Chronic</strong>Soreness</span></a></div><button class="mobile-menu-toggle" aria-label="Toggle menu"><span class="hamburger"></span></button><ul class="nav-menu"><li><a href="../conditions.html">Conditions</a></li><li><a href="../treatments.html">Treatments</a></li><li><a href="../medications.html">Medications</a></li><li><a href="../exercise.html">Exercise</a></li><li><a href="../nutrition.html">Nutrition</a></li><li><a href="../mental-health.html">Mental Health</a></li></ul></nav></header>
    <main id="main-content">
        <article class="page-header"><h1>Polymyalgia Rheumatica</h1><p>Inflammatory muscle pain in older adults</p></article>
        <section class="content-section">
            <div class="container">
                <h2>What Is Polymyalgia Rheumatica?</h2>
                <p>Polymyalgia rheumatica (PMR) is an inflammatory disorder that causes widespread muscle pain and stiffness, particularly in the shoulders, neck, upper arms, hips, and thighs. It almost exclusively affects people over 50 and is more common in women. The condition typically responds dramatically to corticosteroid treatment.<sup>1</sup></p>

                <h2>Symptoms<sup>2</sup></h2>
                <ul>
                    <li>Pain and stiffness in shoulders and hips</li>
                    <li>Symptoms worse in morning</li>
                    <li>Stiffness lasting more than 45 minutes</li>
                    <li>Difficulty raising arms overhead</li>
                    <li>Trouble getting out of chair</li>
                    <li>Fatigue and malaise</li>
                    <li>Loss of appetite</li>
                    <li>Unintentional weight loss</li>
                    <li>Low-grade fever</li>
                </ul>

                <h2>Key Characteristics</h2>
                <ul>
                    <li>Age over 50 (usually over 70)</li>
                    <li>Symptoms develop rapidly (over days to weeks)</li>
                    <li>Both sides of body affected</li>
                    <li>Dramatic response to prednisone</li>
                    <li>Associated with elevated inflammation markers</li>
                </ul>

                <h2>Diagnosis<sup>3</sup></h2>
                <ul>
                    <li>No single definitive test</li>
                    <li>Elevated ESR and CRP</li>
                    <li>Clinical presentation</li>
                    <li>Response to steroids helps confirm</li>
                    <li>Rule out other conditions</li>
                    <li>Ultrasound may show bursitis</li>
                </ul>

                <h2>Giant Cell Arteritis Link</h2>
                <ul>
                    <li>PMR and GCA often occur together</li>
                    <li>10-30% of PMR patients develop GCA</li>
                    <li>GCA can cause vision loss</li>
                    <li>New headache requires urgent evaluation</li>
                    <li>Jaw claudication is warning sign</li>
                </ul>

                <h2>Treatment</h2>
                <h3>Corticosteroids</h3>
                <ul>
                    <li>Prednisone is first-line treatment</li>
                    <li>Typically 15-20 mg daily initially</li>
                    <li>Rapid improvement expected</li>
                    <li>Gradual tapering over 1-2 years</li>
                    <li>Some need longer treatment</li>
                </ul>

                <h3>Managing Side Effects</h3>
                <ul>
                    <li>Bone protection (calcium, vitamin D)</li>
                    <li>Monitor for diabetes</li>
                    <li>Watch for infections</li>
                    <li>Use lowest effective dose</li>
                </ul>

                <h2>Prognosis</h2>
                <ul>
                    <li>Most respond well to treatment</li>
                    <li>Relapses common during tapering</li>
                    <li>Average treatment duration 1-2 years</li>
                    <li>Some need longer-term steroids</li>
                    <li>Most eventually achieve remission</li>
                </ul>

                <h2>References</h2>
                <ol>
                    <li>Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. <em>Lancet</em>. 2008;372(9634):234-245.</li>
                    <li>Dasgupta B, Cimmino MA, Kremers HM, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. <em>Arthritis Rheum</em>. 2012;64(4):943-954.</li>
                    <li>Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis: a systematic review. <em>JAMA</em>. 2016;315(22):2442-2458.</li>
                </ol>
            </div>
        </section>
    </main>
    <footer class="footer"><div class="container"><p class="disclaimer">The information provided is for educational purposes only and is not medical advice.</p><p class="copyright">Â© 2024 ChronicSoreness. All rights reserved.</p></div></footer>
    <script src="../js/main.js"></script>
</body>
</html>
